Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Aion Therapeutic Inc.  is an early-stage cannabinoid extraction company based in Oliver, BC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. The Company will offer contract tolling extraction, sale of bulk oil and development of both proprietary Aion Cannabis branded and white labelled products once licensed to do so.

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.


Alliance Growers Corp. (ACG:CSE) is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.

Alliance Growers and Pharmagreen Biotech Inc. are jointly developing a 63,000-square foot facility, the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The main facility is the Cannabis Biotech Centre which will grow Cannabis plantlets utilizing the proprietary “Chibafreen Invitro Plant Production System” for tissue culture propagation, allowing more tissue cultured plantlets to be produced in less space and less time. 

Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health’s industry-leading software systems provide the platform for the company’s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America.

T​​hrough Alternate Health’s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders. For more information about Alternate Health Corp., visit



AMP German Cannabis Group Inc. is a specialized German importer of EU-GMP medical cannabis.  

Asia Green Biotechnology Corp. is an early stage agricultural and biotechnology company focusing, first, on the introduction and application of new and important hemp strains in various regions of Asia, and, second, the conduct of research and testing to develop and introduce new and important industrial, medicinal and alternative by-products derived from those hemp and related plant strains.

Each Right entitles the holder to receive, for no additional consideration, one-tenth of one Subordinate Voting Share, subject to certain adjustments. Any Right that has not been converted by 5:00 p.m. on May 24, 2021 shall be null and void.

Ayr Strategies Inc. - Subordinate Voting Shares

Ayr is a vertically-integrated cannabis company in the United States focused on recreational and wellness applications, with an initial anchor portfolio of vertically-integrated operations in the Eastern and Western United States.

Investor Note: In addition to the 15,879,773 Subordinate Voting Shares that are listed and trading, there are (a) 3,696,486 reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares that are issued and outstanding but not listed, (b) 1,233,595 reserved for issuance pursuant to certain make-whole provisions in certain share purchase agreements to which Ayr is a party, assuming a C$7.15 Subordinate Voting Share market price, and (c) 8,373,792 reserved for issuance pursuant to the conversion rights attached to the Exchangeable Shares issued and outstanding but not listed. The total number of issued Subordinate Voting Shares assuming all the foregoing are exercised or converted into the listed class or issued, as applicable, would be 27,125,858. The foregoing does not include the Subordinate Voting Shares reserved for issuance pursuant to the (w) exercise rights attached the Warrants which are issued and outstanding and listed, (x) conversion rights attached to the Rights which are issued and outstanding and listed, (y) conversion rights attached to the Restricted Exchangeable Shares granted as equity incentive compensation that are granted but not listed, and (z) conversion rights attached to the Restricted Exchangeable shares that are available for issuance under Ayr’s long-term equity incentive plan but not granted.  The number representing the "total equity shares, as if converted" does not take into account the Subordinate Voting Shares resulting from the exercise of the Warrants or the conversion of the Rights.

Each Warrant is exercisable to purchase one Subordinate Voting Share at a price of C$11.50 per share, subject to certain adjustments. The Warrants expire on May 24, 2024, and Ayr may accelerate such expiry (except with respect to Warrants held by Mercer Park CB, L.P., the sponsor of CSAC) by providing 30 days’ notice in the event that the closing price of the Subordinate Voting Shares equals or exceeds C$18.00 (as may adjusted in accordance with the terms thereof) for any 20 trading days within a 30-day trading period, in which case the expiry date shall be the date which is 30 days following the date on which such notice is provided. 

Ayr Strategies Inc. - Subordinate Voting Shares

Based in Vancouver, British Columbia, BC Craft Supply Co. has aggregated the best legacy-era talent from Canada's craft cannabis industry, which boasts an international reputation. The team at BC Craft supports the most talented cannabis cultivators in Canada to transition into their supply chain, bringing with them their unique cultivars and years of experience with the plant. In exchange for support with licensing, compliance and distribution, cultivators will sign on as a BC Craft supplier. This makes BC Craft uniquely positioned to be the premium cannabis brand in Canada. 

BC Craft’s subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a license to sell medical cannabis products in Canada.

Contact The Team

How can we help you?

Contact the CSE team to find out more.



Latest CSE News

Upcoming Events


Jamaica Stock Exchange 16th Annual Regional Investments and Capital Markets Conference

Tuesday, January 26, 2021 - 6:30pm to Thursday, January 28, 2021 - 4:00pm